Oryzon Genomics

oryzon.com

Total Raised

$19.27M

Investors Count

Deal Terms

Funding, Valuation & Revenue

5 Fundings

Oryzon Genomics has raised $19.27M over 5 rounds.

Oryzon Genomics's latest funding round was a PIPE for $34.16M on April 24, 2025.

Oryzon Genomics's valuation in October 2015 was $110M.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
4/24/2025	PIPE	$34.16M	Undisclosed Investors	$XXM	$X.XXB ((X.XXx)) FY XXXX	2
12/15/2015	IPO		Subscribe to see more	$XXM	0 FY undefined	10
10/27/2015	Unattributed VC	$XXM	Subscribe to see more	$110M	0 FY undefined	10
5/18/2015	Grant	$XXM	Subscribe to see more	$XXM	0 FY undefined	10
	Other Investors		Subscribe to see more	$XXM	0 FY undefined	0

Date	4/24/2025	12/15/2015	10/27/2015	5/18/2015
Round	PIPE	IPO	Unattributed VC	Grant	Other Investors
Amount	$34.16M		$XXM	$XXM
Investors	Undisclosed Investors	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Valuation	$XXM	$XXM	$110M	$XXM	$XXM
Revenue	$X.XXB ((X.XXx)) FY XXXX	0 FY undefined	0 FY undefined	0 FY undefined	0 FY undefined
Sources	2	10	10	10	0

Oryzon Genomics Deal Terms

1 Deal Term

Oryzon Genomics's deal structure is available for 1 funding round, including their Unattributed VC from October 27, 2015.

Round	Unattributed VC
Funding Date	$XXM
Pre-Money Valuation	$XXM
Post-Money Valuation	$XXM
Amount Raised	$XXM
Shares Authorized
Issuance Price
Dividend Rate
Liquidation Preferences
Liquidation Price
Participation
Conversion Price
Anti Dilution
General Voting	$XXM
Board Voting	$XXM
Par Value

Round	Funding Date	Pre-Money Valuation	Post-Money Valuation	Amount Raised	Shares Authorized	Issuance Price	Dividend Rate	Liquidation Preferences	Liquidation Price	Participation	Conversion Price	Anti Dilution	General Voting	Board Voting	Par Value
Unattributed VC	$XXM	$XXM	$XXM	$XXM									$XXM	$XXM

Oryzon Genomics Investors

9 Investors

Oryzon Genomics has 9 investors. Grupo Solventis invested in Oryzon Genomics's Unattributed VC funding round.

First funding	Last Funding	Investor	Rounds	Type	Location
10/27/2015	10/27/2015	Grupo Solventis	1 Unattributed VC	Bank	Spain
00/00/0000	00/00/0000	Joseph Fernandez	Subscribe to see more	Angel Investor (Individual)
00/00/0000	00/00/0000	Capital MAB	Subscribe to see more	Venture Capital	Spain
00/00/0000	00/00/0000	Alzheimer's Drug Discovery Foundation	Subscribe to see more	Non-Profit Foundation	New York
		Grupo Ferrer Internacional	Subscribe to see more	Corporation	Spain

First funding	10/27/2015	00/00/0000	00/00/0000	00/00/0000
Last Funding	10/27/2015	00/00/0000	00/00/0000	00/00/0000
Investor	Grupo Solventis	Joseph Fernandez	Capital MAB	Alzheimer's Drug Discovery Foundation	Grupo Ferrer Internacional
Rounds	1 Unattributed VC	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Board Seats
Type	Bank	Angel Investor (Individual)	Venture Capital	Non-Profit Foundation	Corporation
Location	Spain		Spain	New York	Spain

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.

How VCs Use CB Insights

Professional Services

Platform Overview